| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health
|
Oct 16, 2026 | BUY |
Hold
-0.1% avg upside
10 analysts
|
$55.00
41.59% Upside
|
+0.0% | Β· |
|
ANIP
ANI Pharmaceuticals
|
Aug 10, 2026 | BUY |
Strong Buy
+39.4% avg upside
12 analysts
|
$115.00
59.01% Upside
|
-6.5% | Β· |
|
AMPH
Amphastar Pharmaceuticals
|
May 12, 2025 | HOLD |
Hold
+2.4% avg upside
11 analysts
|
$30.00
15.99% Upside
|
-28.1% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.